MedTrace Logo

Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry

NCT02852252 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 291

Last updated 2021-06-18

No results posted yet for this study

Summary

The study objective is to collect prospective data on cancer patients who undergo surgery and intraoperative imaging. The registry will include (but not limited to) cancer type, stage, intraoperative challenges to the surgeon, usage and results of intraoperative imaging, and recurrence surveillance.

Conditions

Interventions

DRUG

OTL38

Patients will be given imaging agent 2-3 hours before surgery to assist in imaging.

DRUG

ICG

Patients will be given imaging agent 24 hours before surgery to assist in imaging.

Sponsors & Collaborators

Principal Investigators

  • Sunil Singhal · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02852252 on ClinicalTrials.gov